Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Immunohistochemistry (IHC) analysis
GENETIC
2 trials
Sponsors
Pancreatic Cancer Research Team
, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions
Prostate Cancer
Stage IV Pancreatic Cancer
Phase 1
Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
Completed
NCT01488552
Pancreatic Cancer Research Team
Stage IV Pancreatic Cancer
Start: 2011-11-30
End: 2016-08-31
Updated: 2016-08-18
Unknown Phase
Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients
Completed
NCT05819606
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Prostate Cancer
Start: 2023-04-15
End: 2024-12-31
Updated: 2025-09-22
Related Papers
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Journal of Visualized Experiments
2015-06-20
27 citations
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Journal of Visualized Experiments
2015-06-20
3 citations
Phase II study of nab-paclitaxel/gemcitabine (NabP-Gem) alternating with FOLFIRI as 1st line therapy ( Rx) in patients (pts) with metastatic pancreatic cancer (mPC).
Journal of Clinical Oncology
2015-05-20
Phase II study of induction therapy with gemcitabine and nab-paclitaxel followed by consolidation with mFOLFIRINOX in patients with metastatic pancreatic cancer.
Journal of Clinical Oncology
2014-01-20
9 citations